These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1348 related articles for article (PubMed ID: 16929250)

  • 1. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermedin is upregulated and attenuates renal fibrosis by inhibition of oxidative stress in rats with unilateral ureteral obstruction.
    Qiao X; Wang L; Wang Y; Zhao N; Zhang R; Han W; Peng Z
    Nephrology (Carlton); 2015 Nov; 20(11):820-31. PubMed ID: 26014968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis.
    Shen N; Lin H; Wu T; Wang D; Wang W; Xie H; Zhang J; Feng Z
    Kidney Int; 2013 Jul; 84(1):64-77. PubMed ID: 23486519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis.
    Grygielko ET; Martin WM; Tweed C; Thornton P; Harling J; Brooks DP; Laping NJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):943-51. PubMed ID: 15769863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
    Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
    Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
    Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
    J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific molecular targeting of renal injury in obstructive nephropathy.
    Chevalier RL
    Kidney Int; 2006 Oct; 70(7):1200-1. PubMed ID: 16988728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
    Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
    Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine ameliorates renal interstitial fibrosis induced by unilateral ureteral obstruction in rats.
    Wang FM; Yang YJ; Ma LL; Tian XJ; He YQ
    Nephrology (Carlton); 2014 Sep; 19(9):542-51. PubMed ID: 24754438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.
    Xie XS; Li FY; Liu HC; Deng Y; Li Z; Fan JM
    Arch Pharm Res; 2010 Feb; 33(2):275-84. PubMed ID: 20195829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors.
    Yang YL; Liu YS; Chuang LY; Guh JY; Lee TC; Liao TN; Hung MY; Chiang TA
    Endocrinology; 2009 Feb; 150(2):727-40. PubMed ID: 18832104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
    Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
    J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats.
    Terashima H; Kato M; Yasumo H; Tsuchida H; Mizuno M; Sada T
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F792-801. PubMed ID: 20660018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
    Qi FH; Cai PP; Liu X; Si GM
    Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
    Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
    PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction.
    Miyajima A; Chen J; Lawrence C; Ledbetter S; Soslow RA; Stern J; Jha S; Pigato J; Lemer ML; Poppas DP; Vaughan ED; Felsen D
    Kidney Int; 2000 Dec; 58(6):2301-13. PubMed ID: 11115064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human umbilical cord-derived mesenchymal stem cells conditioned medium attenuate interstitial fibrosis and stimulate the repair of tubular epithelial cells in an irreversible model of unilateral ureteral obstruction.
    Liu B; Ding FX; Liu Y; Xiong G; Lin T; He DW; Zhang YY; Zhang DY; Wei GH
    Nephrology (Carlton); 2018 Aug; 23(8):728-736. PubMed ID: 28667820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
    Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
    J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.